Vigil Neuroscience, Inc. [Rocket]

Overview

Vigil Neuroscience, Inc.

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
10/12/2023	8-K	Quarterly results
08/08/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/08/2023	8-K	Quarterly results
08/07/2023	4	Silber Christopher (Chief Medical Officer) has filed a Form 4 on Vigil Neuroscience, Inc.
08/07/2023	3	Silber Christopher (Chief Medical Officer) has filed a Form 3 on Vigil Neuroscience, Inc.
06/09/2023	4	Bruhn Suzanne Louise (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
06/09/2023	4	Thistle Mary (Director) has filed a Form 4 on Vigil Neuroscience, Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21
Revenues	0.0	0.0
Cost of goods sold	0.0	0.0
Gross profit	0.0	0.0
Selling, general and administrative	68.9	42.4
EBIT	-67.7	-44.2
Pre-tax income	-68.3	-43.3
Income taxes	0.0	0.0
Tax rate	0.0%	0.0%
Net income	-68.3	-43.3

Diluted EPS	($2.16)	($28.26)
Shares outstanding (diluted)	31.7	1.5

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy